1st Edition 2018
Hardback (10 Nov 2017)
Includes delivery to the United States
10+ copies available online - Usually dispatched within 7 days
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
| ISBN: | 9783319637563 |
| Publisher: | Springer International Publishing |
| Imprint: | Springer |
| Pub date: | 10 Nov 2017 |
| Edition: | 1st Edition 2018 |
| Language: | English |
| Number of pages: | 331 |
| Weight: | 6387g |
| Height: | 235mm |
| Width: | 155mm |
| Spine width: | 21mm |
Preventable
Hardback
Published 21 Apr 2022
$22.83off
How to Prevent the Next Pandemic
Hardback
Published 03 May 2022
Save $22.83
$6.48off
The Eyes of Darkness
Paperback
Published 05 May 2016
Save $6.48
$5.28off
The Living Medicine
Hardback
Published 24 Oct 2024
Save $5.28
$8.57off
Basic Clinical Radiobiology
Paperback
Published 08 Jan 2025
Save $8.57
Social Skills Training for Schi...
Hardback
Published 12 Nov 2024
$1.60off
Social Skills Training for Schi...
Paperback
Published 14 Oct 2024
Save $1.60
$0.68off
The Adventures of Cancer Bitch
Paperback
Published 28 Nov 2024
Save $0.68
